Moderna Inc.

NASDAQ: MRNA · Real-Time Price · USD
28.00
1.31 (4.91%)
At close: Aug 15, 2025, 3:59 PM
28.04
0.12%
After-hours: Aug 15, 2025, 07:58 PM EDT

Moderna Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.06B 3.14B 3.2B 5.06B 5.03B 5.16B 6.83B 9.16B 10.55B 14.77B 18.88B 20.68B 22.28B 21.93B 17.74B 11.36B 6.69B 2.54B
Cost of Revenue
1.46B 1.46B 1.46B 1.65B 3.38B 4B 4.69B 5.68B 4.54B 5.19B 5.42B 4.45B 4.07B 3.44B 2.62B 1.68B 967.14M 224.74M
Gross Profit
1.6B 1.68B 1.74B 3.4B 1.65B 1.16B 2.13B 3.48B 6.01B 9.58B 13.46B 16.23B 18.21B 18.49B 15.12B 9.68B 5.72B 2.31B
Operating Income
-3.27B -3.73B -3.94B -2.69B -4.63B -5.14B -4.24B -2.67B 513M 4.83B 9.42B 13.25B 15.64B 16.26B 13.3B 7.61B 3.82B 633.72M
Interest Income
365M 395M 425M 437M 439M 432M 421M 405M 358M 294M 200M 120M 66M 29M 18M 15.2M 16.77M 20.86M
Pretax Income
-2.94B -3.41B -3.61B -2.35B -4.33B -4.8B -3.94B -2.36B 818M 5.04B 9.57B 13.33B 15.66B 16.25B 13.29B 7.6B 3.82B 639.65M
Net Income
-2.9B -3.36B -3.56B -2.22B -5.87B -5.97B -4.71B -3.47B 1.21B 4.78B 8.36B 11.77B 14.05B 14.64B 12.2B 7.06B 3.49B 598.17M
Selling & General & Admin
1.07B 1.11B 1.17B 1.29B 1.45B 1.52B 1.55B 1.45B 1.29B 1.17B 1.13B 958M 848M 758M 567M 444.99M 324.99M 240.99M
Research & Development
3.81B 4.34B 4.51B 4.79B 4.81B 4.74B 4.84B 4.65B 4.31B 3.87B 3.29B 2.73B 2.43B 2.14B 1.99B 2.1B 1.93B 1.66B
Other Expenses
-18M -38M -1M 11M 18M 38M -22M 41M -103M -286M -388M -715M -711M -667M -735M -480.71M -348.67M -217.64M
Operating Expenses
4.87B 5.41B 5.68B 6.09B 6.29B 6.3B 6.37B 6.14B 5.5B 4.75B 4.04B 2.98B 2.57B 2.23B 1.82B 2.07B 1.9B 1.68B
Interest Expense
13M 19M 24M 24M 28M 35M 38M 42M 40M 32M 29M 25M 21M 21M 18M 15.51M 14.34M 11.22M
Selling & Marketing Expenses
n/a n/a n/a 204M 204M 204M 204M 121M 121M 121M 121M n/a n/a n/a n/a n/a -541K -163K
Cost & Expenses
6.33B 6.87B 7.14B 7.75B 9.67B 10.29B 11.06B 11.83B 10.04B 9.95B 9.46B 7.42B 6.64B 5.68B 4.44B 3.75B 2.87B 1.9B
Income Tax Expense
-42M -49M -46M -129M 1.53B 1.17B 772M 1.11B -389M 257M 1.21B 1.56B 1.61B 1.62B 1.08B 542.47M 324.34M 41.48M
Shares Outstanding (Basic)
388M 386M 385M 385M 384M 382M 381M 381M 381M 386M 385M 390M 396M 402M 405M 404M 402M 400M
Shares Outstanding (Diluted)
388M 386M 385M 399M 384M 382M 395M 381M 381M 405M 405M 412M 419M 426M 431M 434M 431M 430M
EPS (Basic)
-7.53 -8.73 -9.29 -5.81 -15.37 -15.66 -12.38 -9.14 3.06 12.23 21.12 29.34 34.94 36.32 30.28 17.56 8.70 1.46
EPS (Diluted)
-7.53 -8.73 -9.29 -5.83 -15.39 -15.68 -12.4 -9.33 2.73 11.59 19.97 27.64 32.81 34.03 28.29 16.31 8.02 1.25
EBITDA
-2.72B -3.19B -3.39B -2B -3.78B -4.19B -3.29B -1.82B 1.22B 5.42B 9.94B 13.69B 15.97B 16.56B 13.53B 7.78B 3.93B 689.68M
EBIT
-2.93B -3.39B -3.58B -2.33B -4.3B -4.77B -3.9B -2.31B 858M 5.07B 9.6B 13.36B 15.69B 16.27B 13.3B 7.62B 3.83B 650.87M
Depreciation & Amortization
208M 192M 189M 331M 528M 577M 619M 497M 361M 347M 348M 346M 303M 296M 232M 161.71M 100.21M 38.8M